Skin Excision Market Size, Growth, Trends | Report 2022-2030
The global skin excision market was valued at USD 27.8 billion in 2021 and it is predicted to surpass around USD 59.3 billion by 2030 with a CAGR of 8.78% from 2022 to 2030.
Report Highlights
The market expansion of skin excision is primarily caused by the rising elderly population, rising obesity incidence, and rising aesthetic consciousness. The skin excision method has changed over a short period due to expanding demand, rising discretionary income, growing awareness, and adoption of cosmetic procedures, technological improvement in the devices used for surgeries, advancements in drugs and therapies, availability of qualified surgeons, and improved healthcare facilities.
Skin excision is a procedure in which excess skin is removal removed and people who lose a lot of weight through weight loss surgery or lifestyle changes opt for such treatment as their skin becomes loose and sags. There are various types of procedures for excess skin removal including Brachioplasty, Mastopexy, Rhytidectomy, Thigh lift, Neck Lift, Brow lift, Abdominoplasty, etc. These procedures are carried out at hospitals and clinics where board-certified surgeons perform such skin excision procedures.
People have become more conscious about their personalities and appearances with major influence from social media. To overcome body flaws because of aging, pregnancy, heredity, or high BMI, people opt for reconstructive surgeries. The ratio of females appearing for surgery seems to be higher than males. For instance, according to ISAPS report 2020, 92.0% of the total procedures of abdominoplasty (Tummy Tuck) were performed on females which were approximately 703,778 in number.
The demand for skin excision procedures shrank in 2020 due to the outbreak of COVID as global restrictions and lockdown were imposed in most countries initially, and many non-cosmetic surgical procedures were halted. However, ISAPS reported, that the willingness to opt for invasive as well as non-invasive treatments globally has increased post-pandemic.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 27.8 billion |
| Revenue Forecast by 2030 | USD 59.3 billion |
| Growth rate from 2022 to 2030 | CAGR of 8.78% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Procedure type, end-use, region |
| Companies Covered | Long Island Plastic Surgical Group, US; Nazarian Plastic Surgery, US; Charlotte: Piedmont Plastic Surgery & Dermatology, US; Bella Sante MD Cosmetic and Laser Clinic, Canada; American Hospital of Paris Plastic Surgery Unit, France |
Procedure Type Insights
The mastopexy procedure segment held a lucrative revenue share of more than 37.64% in 2021. The segment is also anticipated to witness a healthy CAGR of 9.5% from 2022 to 2030. Mastopexy is a surgical procedure that lifts and reshapes sagging breasts by removing excess skin and tightening supporting tissues. The average cost of mastopexy is approximately between USD 10,000-14,000, plus anesthesia and operating room fees. According to the Plastic Surgery Statistics Report, 87,051 Mastopexy procedures were conducted in the year 2020. Predominantly females undergo this surgery due to breast ptosis. Age, higher BMI, weight gain during pregnancy, and lack of upper body exercise are some of the factors responsible for breast ptosis. The rising prevalence of weight and hormonal fluctuations, aging, heredity, and obesity are expected to increase the occurrence of sagging breasts. Increasing aesthetic appearance consciousness and body awareness is expected to drive the market.
End-use Insights
The clinics' segment dominated the market for skin excision and accounted for the largest revenue share of 68.66% in 2021. This dominion can be contributed to their less waiting period and better post-treatment care and facilities for these skin excision procedures. Clinics have board-certified specialist surgeons who provide personalized treatments to patients. For instance, according to the ISAPS report 2020, around 59.4% of surgeons perform Brachioplasty worldwide. Skin Excision procedure if not conducted properly has risks and side effects.
To avoid these side effects, it is necessary for a patient that the surgery is performed by a board-certified surgeon as they are experienced and trustworthy. Moreover, the skin excision procedure requires a longer period of recovery and many sessions to complete it. In the case of hospitals, the waiting period for getting appointments is high as compared to the clinics, and hence, clinics are expected to experience growth over the forecast period.
Regional Insights
North America dominated the market for skin excision and accounted for the largest revenue share of 41.7% in 2021. Expanding geriatric populace, and the rising prevalence of obesity due to poor dietary habits and sedentary lifestyles are the main considerations crediting to its bigger piece of the market. The region also has high awareness, technological advancement, and access to cosmetic surgery services with a strong range of disposable income thereby leading to high demand.
In the Asia Pacific, the market for skin excision is anticipated to witness significant growth over the forecast period owing to the rising population, growing awareness, and increasing healthcare facilities in this region. The developing countries in this region have expanded their healthcare facilities and people from this region are becoming very aware of these procedures because of medical tourism and increased use of the internet and social media. For instance, according to the ISAPS report, on average 5.2% of patients opt forend cosmetic surgical procedures in India.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Skin Excision Market
5.1. COVID-19 Landscape: Skin Excision Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Skin Excision Market, By Procedure Type
8.1. Skin Excision Market, by Procedure Type, 2022-2030
8.1.1. Brachioplasty
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Mastopexy
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Rhytidectomy
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Panniculectomy
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Thigh Lift
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Tummy Tuck
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Neck Lift
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.18. Brow Lift
8.1.8.1. Market Revenue and Forecast (2017-2030)
8.1.9. Breast Reduction
8.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Skin Excision Market, By End-use
9.1. Skin Excision Market, by End-use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Clinics
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Skin Excision Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Long Island Plastic Surgical Group, US
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Nazarian Plastic Surgery, US
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Charlotte: Piedmont Plastic Surgery & Dermatology, US
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bella Sante MD Cosmetic and Laser Clinic, Canada
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. American Hospital of Paris Plastic Surgery Unit, France
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers